BioTime, Inc Stock News

Brooklyn ImmunoTherapeutics Inc (NYSE: BTX) has announced a publication in Breast Cancer Research, which demonstrates how multiplex immunofluorescence (mIF) may be used to characterize the immunol

This clinical-stage biotech was one of April's brightest stars.

An unknown biotech has turned its early investors into millionaires over the past month. Can it continue its momentum?

The stock price of Brooklyn Immunotherapeutics Inc (NYSEAMERICAN: BTX) increased from over 64% pre-market as it went from $49.80 to over $82 pre-market. This is why it happened.

Brooklyn Immuno Therapeutics Inc. (NYSE: BTX) shares are soaring Friday. The stock is likely continuing its run after the company paid $1 million towards the acquisition of a license for Factor Biosc

Today, investors in BTX stock appear to be on board in a big way with a major announcement from this hot meme stock and Reddit favorite. The post BTX Stock: The Big News That Has Brooklyn ImmunoTherap

Shares of Brooklyn ImmunoTherapeutics have surged more than 800% over the past month despite a lack of a major catalyst that could explain the price jump on a fundamental basis.

The stock price of Brooklyn ImmunoTherapeutics LLC (NYSE American: BTX) increased by over 30% during intraday trading. This is why it happened.

BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics Reports Inducement Grants

The stock price of Brooklyn Immunotherapeutics (NYSEAMERICAN: BTX) increased 27.33%. This is why it happened.

Investors getting ready for another busy day of trading need to make sure they know the biggest pre-market stock movers before markets open. The post Today's Biggest Pre-Market Stock Movers: 10 Top Ga

BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics Completes Reverse Merger with NTN Buzztime